{"id":"dm-1992","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"DM-1992 works by modulating the activity of certain ion channels in the brain, which helps to reduce the transmission of pain signals. This mechanism is thought to be responsible for its analgesic effects.","oneSentence":"DM-1992 is a small molecule that targets the central nervous system to treat pain.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:33:32.501Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic pain"}]},"trialDetails":[{"nctId":"NCT01515410","phase":"PHASE2","title":"Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations","status":"COMPLETED","sponsor":"Depomed","startDate":"2012-01","conditions":"Parkinson's Disease, Motor Fluctuations","enrollment":34}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"DM-1992","genericName":"DM-1992","companyName":"Depomed","companyId":"depomed","modality":"Small molecule","firstApprovalDate":"","aiSummary":"DM-1992 is a small molecule that targets the central nervous system to treat pain. Used for Chronic pain.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}